ROYALTY PHARMA PLC

Ticker: RPRX CUSIP: G7709Q104 Class: Common Stock

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 27,511 Value ($000) $971 Avg Close $36.20 Range $34.08 - $38.00

Q4 2024

Shares 59,755 Value ($000) $1,524 Avg Close $26.52 Range $24.05 - $28.55

Q4 2023

Shares 95,382 Value ($000) $2,679 Avg Close $27.48 Range $26.07 - $29.63

Q3 2023

Shares 67,937 Value ($000) $1,844 Avg Close $29.70 Range $25.92 - $31.55

Q3 2022

Shares 285,034 Value ($000) $11,452 Avg Close $42.71 Range $39.60 - $44.66

Q1 2022

Shares 197,889 Value ($000) $7,710 Avg Close $39.27 Range $36.15 - $42.62

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	27,511	$971	$36.20	$34.08 - $38.00
Q4 2024	59,755	$1,524	$26.52	$24.05 - $28.55
Q4 2023	95,382	$2,679	$27.48	$26.07 - $29.63
Q3 2023	67,937	$1,844	$29.70	$25.92 - $31.55
Q3 2022	285,034	$11,452	$42.71	$39.60 - $44.66
Q1 2022	197,889	$7,710	$39.27	$36.15 - $42.62